FOR IMMEDIATE RELEASE
23 October 2023 – SYNDEO Medical, a leading provider of fully integrated custom procedural solution products, has entered into a multi-year, master distribution agreement signifying its entrance into the African markets, specifically the Sub-Saharan region. The company is committed to collaborating with interventional and surgical healthcare providers to enhance patient experience, deliver value to healthcare providers and institutions, and empower outcomes throughout Africa.
As part of this milestone entry into the African markets, SYNDEO Medical intends to launch its portfolio of innovative brands of minimally invasive interventional and surgical products, including SYNDEOPack™, Xssential™ Rapid Delivery Procedure Packs, SYNDEOPack AP™, and its portfolio of standalone interventional accessories. These innovative products are specifically designed to meet the unique needs of interventional and surgical healthcare providers, enabling them to streamline procedures, optimize workflow efficiency, and enhance the quality of patient care.
“First, this is a very big day for the SYNDEO Medical family and our respective partners that worked tirelessly to put an agreement together to bring our products to over 40 countries so my gratitude to the teams that were involved. The African markets represent a dynamic and promising growth landscape, offering significant opportunities for healthcare innovation and advancements. We believe our portfolio of products is perfectly suited for the African markets and will play an important role in the continued growth and modernization of interventional and surgical care throughout the region," said Justin J. Lampropoulos, CEO of SYNDEO Medical.
"We are committed to supporting interventional and surgical healthcare providers in Africa by providing the solutions they need to deliver exceptional patient care. Our mission is to collaborate with interventional and surgical healthcare providers and theri respective institutions to ensure that they have access to the latest, procedural solutions that are deisgned to meet their specific local and procedural needs. We believe that by enhancing the capabilities of these incredible healthcare providers, we can make a significant difference in patient outcomes," further added Lampropoulos.
Under the terms of the agreement, SYNDEO Medical brands will be made available in each African jurisdiction where regulatory approval is obtained and maintained, in accordance with all applicable regulations.
For more information, please contact SYNDEO Medical or visit syndeomedical.be.
SYNDEO Medical is engaged in the design and development of fully integrated custom procedural solution products. Founded in 2022 by Justin J. Lampropoulos and headquartered in Belgium, SYNDEO Medical is dedicated to pushing the boundaries of healthcare innovation. Specializing in minimally invasive interventional and surgical products, SYNDEO Medical serves healthcare providers worldwide through a network of distribution partners and sales representatives. The company is committed to positively impacting lives through elevating patient experience, delivering meaningful value, and empowering outcomes.
All trademarks and registered trademarks mentioned in this press release are the property of their respective owners. The availability of the products may vary in different jurisdictions. Availability is subject to applicable regulatory requirements.